Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study

by Stefan Heinrich, Marc Besselink, Markus Moehler, Jean-Luc van Laethem, Michel Ducreux, Peter Grimminger, Jens Mittler, Hauke Lang, Manfred P. Lutz, Mickael Lesurtel, on behalf of the Scientific and Research Committee of the E-AHPBA and the EORTC pancreas working group
Published 2019-07-01